Please Wait.....
Report
Baxter International Inc. (BAX:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360 Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends
Company Report I 2024-08-12 I 135 Pages I Quaintel Research
Report Summary
Baxter International Inc. (BAX:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360 Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of Baxter International Inc.'s business operations. It provides a detailed analysis of the company's financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.
The report begins with in-depth information about Baxter International Inc. including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.
Next, the report assesses Baxter International Inc.'s strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. The PESTLE analysis evaluates the external factors impacting the company's operations and market environment. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of Baxter International Inc.'s overall strategic standing and supports informed decision-making and strategic planning.
The report also covers Baxter International Inc.'s financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares Baxter International Inc.'s financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors' operations.
Finally, the report includes recent news and deal activities undertaken by Baxter International Inc. enhancing awareness of the company's business trends, growth perspectives, and more.
Key Highlights
Baxter International Inc (Baxter) is a provider of a range of healthcare products. Its product and service offerings include dialysis in acute and chronic conditions, sterile intravenous solutions, generic injectable pharmaceuticals, parenteral nutrition therapies, infusion systems and devices, inhaled anesthetics and surgical hemostat and sealant products. The company's products find application in hospitals, rehabilitation centres, kidney dialysis centres, nursing homes, and patients at home. Baxter distributes its products through direct sales force and a network of independent distributors, drug wholesalers, specialty pharmacies and other alternative site providers. The company has operations in the Americas, the Middle East, Africa, Europe and Asia-Pacific. Baxter is headquartered in Deerfield, Illinois, the US.
Baxter International Inc. in the News:-
- 17-Jul-2024 - Baxter to Host Second-Quarter 2024 Financial Results Conference Call for Investors
- 16-Jul-2024 - Baxter Declares Quarterly Dividend
- 10-Jul-2024 - Baxter Publishes Annual Corporate Responsibility Report, Highlighting Continued Focus on Creating Lasting Impact
- 29-May-2024 - New Cohort Study Data Shows Baxter's Expanded Hemodialysis - Known as HDx Therapy - is Associated with Approximately 25% Lower Mortality Rate for up to Four Years
- 15-May-2024 - Baxter Announces Mission and Logo for Proposed Kidney Care Company Vantive
Scope
- Tactical Analysis:- Various strategic frameworks to gain insights into a company's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
- Business Strategy:- Contributes to shaping the company's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
- Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company's future prospects. These components collectively contribute to understanding the financial health and market perception of the company.
- Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
- Competitive Landscape:- An identification of the company's main competitors, providing insights into the competitive landscape it operates in.
Reasons to Buy
- Comprehensive Understanding of the Baxter International Inc.'s internal and external factors through SWOT analysis, PESTLE analysis, Financial Analysis, and Competitors Benchmarking.
- Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
- Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
- Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
- Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation.
- Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.
Additionally, available deep-dive analysis on the company Baxter International Inc.:
- Baxter International Inc. Value Chain Analysis
- Baxter International Inc. Porter's Five Forces Analysis
- Baxter International Inc. VRIO Analysis
- Baxter International Inc. BCG Analysis
- Baxter International Inc. Segmentation, Targeting and Positioning (STP) Analysis
- Baxter International Inc. Ansoff Matrix Analysis
Table of Contents
COMPANY EXECUTIVE SUMMARY 1
Table of Contents 2
Tables 6
Charts 7
Baxter International Inc. - Key Company Facts 8
Baxter International Inc. - Company Description 9
Baxter International Inc. - Top Executives 10
Baxter International Inc.- Top Executives Biographies 11
Baxter International Inc.- Head Office & Locations 14
Head Office - Country 14
Key Subsidiaries 15
Baxter International Inc. - Products and Services 17
Products 17
Services 19
Baxter International Inc. - Historic Events 20
Baxter International Inc. - Company's Management Discussion 22
Baxter International Inc. - Corporate Strategy 34
Baxter International Inc. - Business Description 38
Medical Products and Therapies 39
Healthcare Systems and Technologies 40
Pharmaceuticals 40
Kidney Care 41
Baxter International Inc. - ESG Spotlight 42
Environment 42
Social 43
Corporate Governance 44
Baxter International Inc. - SWOT Analysis 45
Overview 45
Strengths 47
Weaknesses 50
Opportunities 52
Threats 55
Baxter International Inc. - PESTLE Analysis 57
Overview 57
Political Factors 59
Economic Factors 61
Social Factors 62
Technological Factors 63
Legal Factors 64
Environmental Factors 66
Baxter International Inc. - Financial Deep Dive 67
Share Price Trend - Aug-2023 to Aug-2024 (Average Share Closing Price) 67
Profit and Loss Statement 69
Summary of Profit and Loss Statement 69
Balance Sheet 71
Summary of Balance Sheet 71
Cash Flow Statement 73
Summary of Cash Flow Statement 73
Key Financial Ratio Analysis 75
Baxter International Inc. - Ratio Charts 76
Activity Ratio Charts 76
Growth Ratios Charts 77
Leverage Ratio Charts 78
Liquidity Ratio Charts 79
Profitability Ratio Charts 80
Competing Players 81
Snapshot of Competing Players 82
Abbott Laboratories 82
Key Company Facts 82
Company Description 82
Snapshot of Competing Players 84
Boston Scientific Corporation 84
Key Company Facts 84
Company Description 84
Snapshot of Competing Players 86
Fresenius Medical Care AG & Co KGaA 86
Key Company Facts 86
Company Description 86
Snapshot of Competing Players 88
Medtronic plc 88
Key Company Facts 88
Company Description 88
Snapshot of Competing Players 90
Stryker Corporation 90
Key Company Facts 90
Company Description 90
Baxter International Inc. - In the News 92
17-Jul-2024 - Baxter to Host Second-Quarter 2024 Financial Results Conference Call for Investors 92
16-Jul-2024 - Baxter Declares Quarterly Dividend 93
10-Jul-2024 - Baxter Publishes Annual Corporate Responsibility Report, Highlighting Continued Focus on Creating Lasting Impact 93
29-May-2024 - New Cohort Study Data Shows Baxter's Expanded Hemodialysis - Known as HDx Therapy - is Associated with Approximately 25% Lower Mortality Rate for up to Four Years 94
15-May-2024 - Baxter Announces Mission and Logo for Proposed Kidney Care Company Vantive 95
11-Apr-2024 - Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S. 96
01-Apr-2024 - Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy 98
27-Mar-2024 - Baxter to Host Annual Meeting of Stockholders in Virtual Format 100
29-Feb-2024 - Baxter to Present at Raymond James 45th Annual Institutional Investors Conference 102
27-Feb-2024 - Baxter Reinforces Guidance Regarding Urgent Medical Device Correction for Exactamix Pro Due to Software Overfill Error 102
14-Dec-2023 - Baxter Advances First Intravenous (IV) Bag Recycling Pilot for U.S. Hospitals 104
13-Dec-2023 - Baxter to Present at 42nd Annual J.P. Morgan Healthcare Conference 105
11-Dec-2023 - Baxter Publishes Task Force on Climate-related Financial Disclosures (TCFD) Report and is Named to Dow Jones Sustainability Index North America 106
29-Nov-2023 - Baxter Issues Urgent Medical Device Correction for Novum IQ Syringe Infusion Pump Due to Potential Impact of Downstream Occlusions on Infusion Volume 108
06-Nov-2023 - Baxter Highlights New Data at Kidney Week Indicating Sharesource is Associated with a 77% Lower Risk of Home Dialysis Technique Failure 110
16-Oct-2023 - Baxter Launches Digital Image Capture Capability for PanOptic Plus Ophthalmoscope 112
Baxter International Inc. - Key Deals 113
28-Nov-2023 - The Baxter International Foundation and UNICEF Partner to Expand Access to Safe Water and Sanitation in Egypt 113
08-May-2023 - Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to Advent International and Warburg Pincus for $4.25 Billion 115
01-Feb-2023 - Miromatrix and Baxter Announce Collaborative Research Agreement Aiming to Advance Care for Patients with Acute Liver Failure 118
06-Jan-2023 - Baxter Announces Strategic Actions to Enhance Operational Effectiveness, Accelerate Innovation for Patients and Drive Value for Shareholder 120
22-Sep-2022 - The Baxter International Foundation Announces $3 Million In New Grants To Organizations Working To Advance Racial Justice 124
09-Mar-2022 - Digital Diagnostics and Baxter Announce New Partnership to Advance Diabetic Retinopathy Detection 126
13-Dec-2021 - Baxter Completes Acquisition of Hillrom, Creating ~$15 Billion Global Medtech Leader 127
Appendix 129
Definitions 129
SWOT Analysis 129
PESTLE Analysis 129
Value Chain Analysis 129
ESG Spotlight 129
Financial Deep Dive 129
Financial Ratios - 130
Activity Ratios 130
Growth Ratios 131
Leverage Ratios 132
Liquidity Ratios 133
Market Ratios 134
Profitability Ratios 134
Research Methodology 135
Disclaimer 136
Contact Us 136
Tables
Table 1: Baxter International Inc. - Company Facts
Table 2: Baxter International Inc. - Top Executives
Table 3: Baxter International Inc. - Top Executives Biographies
Table 4: Baxter International Inc. - Subsidiaries
Table 5: Baxter International Inc. - Products
Table 6: Baxter International Inc. - Services
Table 7: Baxter International Inc. - Historic Events
Table 8: Baxter International Inc. - Share Price Trend - Aug-2023 to Aug-2024
Table 9: Baxter International Inc. - Ratio Analysis - 2020-2023
Table 10: Baxter International Inc. - Competing Players
Charts
Figure 1: Baxter International Inc.- SWOT Analysis 46
Figure 2: Baxter International Inc. - PESTLE Analysis 58
Figure 3: Baxter International Inc. - Average Share Price Trend - Aug-2023 to Aug-2024 68
Figure 4: Baxter International Inc. - Profit and Loss Statement - 2020-2023 70
Figure 5: Baxter International Inc. - Balance Sheet - 2020-2023 72
Figure 6: Baxter International Inc. - Cash Flow Statement 2020-2023 74
Figure 7: Baxter International Inc. - Activity Ratio Charts 76
Figure 8: Baxter International Inc. - Growth Ratio Charts (Value %) 77
Figure 9: Baxter International Inc. - Leverage Ratio Charts 78
Figure 10: Baxter International Inc. - Liquidity Ratio Charts 79
Figure 11: Baxter International Inc. - Profitability Ratio Charts (Value %) 80
Figure 12: Competing Players - Abbott Laboratories - Key Financials 83
Figure 13: Competing Players - Boston Scientific Corporation - Key Financials 85
Figure 14: Competing Players - Fresenius Medical Care AG & Co KGaA - Key Financials 87
Figure 15: Competing Players - Medtronic plc - Key Financials 89
Figure 16: Competing Players - Stryker Corporation - Key Financials 91
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security